Literature DB >> 105549

A long-term follow-up study in essential cryoglobulinemia.

F Invernizzi, P Pioltelli, R Cattaneo, V Gavazzeni, P Borzini, G Monti, C Zanussi.   

Abstract

In a case series of 56 patients with essential cryoglobulinemia, 35 were followed-up for 4-13 years (mean 7 years). A membranous proliferative glomerulonephritis, which in about half the cases showed a progression to renal insufficiency, was the commonest complication, observed in more than one third of the patients. In 2 patients hepatic cirrhosis became manifest after a completely asymptomatic period and in 2 others a lymphoproliferative disease appeared 2 and 8 years after the onset of purpura. In 51% of patients the intial clinical pattern did not change. In searching for a correlation between the development of nephropathy and cryoglobulin characteristics, none was demonstrated studying the cryoglobulin level, the presence of autoantibody and the complement components.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 105549     DOI: 10.1159/000207638

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

Review 1.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 2.  Reappraisal of the clinical expression of mixed cryoglobulinemia.

Authors:  G Montagnino
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Clonal B cell expansions in patients with essential mixed cryoglobulinaemia.

Authors:  A Perl; P D Gorevic; D H Ryan; J J Condemi; R J Ruszkowski; G N Abraham
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  Systemic lupus erythematosus preceded by long-term cryoglobulinaemia.

Authors:  J Perek; M Mittelman; A Eisbruch; M Djaldetti
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

Review 5.  Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.

Authors:  Dario Roccatello; Simone Baldovino; Daniela Rossi; Osvaldo Giachino; Morteza Mansouri; Carla Naretto; Debora Di Simone; Simona Francica; Roberto Cavallo; Mirella Alpa; Franca Napoli; Luigi M Sena
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

6.  Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.

Authors:  V M Lauta; M A De Sangro
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

7.  Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients.

Authors:  Vladimir Coliche; Marie-Nathalie Sarda; Maurice Laville; Roland Chapurlat; Sylvain Rheims; Pascal Sève; Clémence Théry-Casari; Jean-Christophe Lega; Denis Fouque
Journal:  Clin Kidney J       Date:  2018-11-09

8.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31

Review 9.  Symptomatic cryoglobulinemia.

Authors:  A Dispenzieri
Journal:  Curr Treat Options Oncol       Date:  2000-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.